Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
filingDate |
2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2022542390-A |
titleOfInvention |
Dihydropyrimidine derivatives and their use in the treatment of HBV infection or HBV-induced disease |
abstract |
Provided herein are dihydropyrimidine derivatives useful in the treatment or prevention of HBV infection or HBV-induced diseases, more particularly HBV chronic infection or diseases induced by HBV chronic infection, and pharmaceutical or medical uses thereof. be. |
priorityDate |
2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |